Pinnacle Biologics Appoints James L. Foght PhD to the Board of Directors
Dr. Foght has over 40 years experience in the healthcare and life science industries. He was a co-founder of DuPont Pharmaceuticals and the founder and President of Vector Securities International, a premier investment banking firm specializing in life sciences. He is currently chairman of the Board of Directors of Illinois Ventures LLC, a premier seed and early technology investment firm that commercializes technologies from the University of Illinois and other Midwestern universities. He also holds many advisory positions, and he is board member of the Illinois Emerging Technology Funds, Chairman of PharmaIn Inc. and a former board member at Cambridge Antibody Technology (UK), Acrux Limited (Melbourne, Australia) and Advisory Board Member for Ovation Pharmaceuticals (now Lundbeck).
Most read news
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.